Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Postmenopausal estrogen and cardiovascular disease.

M J Stampfer1, F Grodstein, S Bechtel

  • 1Brigham and Women's Hospital, Boston, USA.

Contemporary Internal Medicine
|August 6, 1994
PubMed
Summary

Supplemental estrogen

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Alternative Healthy Eating Index and Physical Function Impairment in Men.

The journal of nutrition, health & aging·2019
Same author

Reduction in physical function in women after venous thromboembolism.

Journal of thrombosis and haemostasis : JTH·2018
Same author

Mediterranean diet and hip fracture incidence among older adults: the CHANCES project.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2018
Same author

Association of Long-Term Adherence to the MIND Diet with Cognitive Function and Cognitive Decline in American Women.

The journal of nutrition, health & aging·2018
Same author

Excess mortality after hip fracture in elderly persons from Europe and the USA: the CHANCES project.

Journal of internal medicine·2017
Same author

GWAS for executive function and processing speed suggests involvement of the CADM2 gene.

Molecular psychiatry·2015

Area of Science:

  • Cardiovascular Disease Research
  • Menopause Studies
  • Hormone Therapy Impact

Background:

  • Cardiovascular disease (CVD) is a leading cause of mortality in postmenopausal women.
  • Hormone therapy, including supplemental estrogen, has been used to manage menopausal symptoms.
  • The relationship between estrogen therapy and CVD risk remains a critical area of investigation.

Purpose of the Study:

  • To synthesize current evidence on the cardiovascular disease risk associated with supplemental estrogen in postmenopausal women.
  • To identify and evaluate the most current clinical guidelines for managing hormone therapy in this population.

Main Methods:

  • Systematic review and meta-analysis of significant clinical studies.
  • Analysis of data to assess cardiovascular disease event rates.
  • Review of recent clinical practice guidelines from major health organizations.

Main Results:

  • Evidence synthesis indicates a complex interplay between estrogen therapy and cardiovascular disease risk.
  • Current guidelines emphasize individualized treatment decisions based on risk factors.
  • Specific cardiovascular outcomes and risk profiles are detailed in the analyzed studies.

Conclusions:

  • The impact of supplemental estrogen on cardiovascular disease risk in postmenopausal women is multifaceted and depends on various factors.
  • Current clinical guidelines advocate for a personalized approach to hormone therapy, balancing benefits and risks.
  • Further research may refine understanding and therapeutic recommendations.

Related Experiment Videos